{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:17:56Z","timestamp":1791245876393,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"MICINN","doi-asserted-by":"crossref","award":["SAF-2010-17395-FEDER"],"award-info":[{"award-number":["SAF-2010-17395-FEDER"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"crossref","award":["08CSA052383PR"],"award-info":[{"award-number":["08CSA052383PR"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association for International Cancer Research"},{"DOI":"10.13039\/501100004099","name":"Ligue National Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["ANR-07-PCVI-0001-01"],"award-info":[{"award-number":["ANR-07-PCVI-0001-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Community","award":["QLK3-CT2002-02029"],"award-info":[{"award-number":["QLK3-CT2002-02029"]}]},{"name":"European Community","award":["LSHM-CT-2005-018652"],"award-info":[{"award-number":["LSHM-CT-2005-018652"]}]},{"name":"European Community","award":["LSHC-CT-2005-518417"],"award-info":[{"award-number":["LSHC-CT-2005-518417"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.bbalip.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T11:06:53Z","timestamp":1303211213000},"page":"57-69","source":"Crossref","is-referenced-by-count":145,"title":["Modulation of RXR function through ligand design"],"prefix":"10.1016","volume":"1821","author":[{"given":"Efr\u00e9n","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinrich","family":"Gronemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel R.","family":"de Lera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.04.003_bb0005","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.58.4.7","article-title":"The pharmacology and classification of the nuclear receptor superfamily. RETINOID X RECEPTORS (RXRs)","volume":"58","author":"Germain","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0010","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/jm00016a018","article-title":"Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells","volume":"38","author":"Boehm","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.07.029","article-title":"Growth factor-antagonized rexinoid apoptosis involves permissive PPAR\u03b3\/RXR heterodimers to activate the intrinsic death pathway by NO","volume":"16","author":"Shankaranarayanan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrd2397","article-title":"RAR and RXR modulation in cancer and metabolic disease","volume":"6","author":"Altucci","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc2129","article-title":"Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer","volume":"7","author":"Liby","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0035","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/pr.58.4.6","article-title":"International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor \u03b1, farnesoid X receptor \u03b2, liver X receptor \u03b1, liver X receptor \u03b2, and vitamin D receptor","volume":"58","author":"Moore","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.febslet.2007.11.081","article-title":"Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR\u2013RXR complex","volume":"582","author":"Ziouzenkova","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJMra043590","article-title":"Retinoid X receptor heterodimers in the metabolic syndrome","volume":"353","author":"Shulman","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0050","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.041609298","article-title":"Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor","volume":"98","author":"Claudel","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.193.7.827","article-title":"Attenuation of colon inflammation through activators of the retinoid X receptor (RRX)\/peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) heterodimer","volume":"193","author":"Desreumaux","year":"2001","journal-title":"J. Experim. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0060","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/en.2003-1401","article-title":"Retinoid X receptor\u03b3-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet","volume":"145","author":"Haugen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0065","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1210\/en.2004-1538","article-title":"Temporal changes in gene expression in the arcuate nucleus precede seasonal responses in adiposity and reproduction","volume":"146","author":"Ross","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI9422","article-title":"Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse","volume":"106","author":"Brown","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0075","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.93.17.9010","article-title":"RXR gamma null mice are apparently normal and compound RXR\u03b1+\/\u2212\/RXR\u03b3\u2212\/\u2212\/RXR\u03b3\u2212\/\u2212 mutant mice are viable","volume":"93","author":"Krezel","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0080","first-page":"224","article-title":"Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor \u03b1 mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes","volume":"98","author":"Imai","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0085","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.289.5484.1524","article-title":"Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers","volume":"289","author":"Repa","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0095","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1074\/jbc.M110.179499","article-title":"Liver X receptor (LXR) regulates human adipocyte lipolysis","volume":"286","author":"Stenson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0105","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0110","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors","volume":"53","author":"Ferr\u00e8","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0120","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","article-title":"Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/386407a0","article-title":"Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists","volume":"386","author":"Mukherjee","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s001250051193","article-title":"The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction","volume":"42","author":"Lenhard","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/en.2003-0907","article-title":"Activation of the Retinoid X Receptor suppresses appetite in the rat","volume":"145","author":"Ogilvie","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI12864","article-title":"Inhibition of RXR and PPAR\u03b3 ameliorates diet-induced obesity and type 2 diabetes","volume":"108","author":"Yamauchi","year":"2001","journal-title":"J. Clin. Inv."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1210\/en.2005-0690","article-title":"Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes","volume":"147","author":"Leibowitz","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0150","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s001250051642","article-title":"Peroxisome proliferator-activated receptor (PPAR) \u03b3 and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle","volume":"44","author":"Cha","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.59.2.170","article-title":"Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity","volume":"59","author":"Davies","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0160","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.1074\/jbc.M311729200","article-title":"Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db\/db) mice","volume":"279","author":"Shen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1124\/mol.59.4.765","article-title":"Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents","volume":"59","author":"Singh Ahuja","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0170","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1210\/endo.143.8.8930","article-title":"Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat","volume":"143","author":"Liu","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0175","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/jm030565g","article-title":"Structure-based design of potent retinoid X receptor \u03b1 agonists","volume":"47","author":"Haffner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0180","doi-asserted-by":"crossref","first-page":"38317","DOI":"10.1074\/jbc.M505853200","article-title":"Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor \u03b3 and retinoic acid X receptors","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0185","first-page":"1360","article-title":"The rexinoid LG100754 is a novel RXR:PPAR{gamma} agonist and decreases glucose levels in vivo","volume":"15","author":"Cesario","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0190","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.ijo.0801351","article-title":"Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa\/fa rats","volume":"24","author":"Liu","year":"2000","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0195","first-page":"1334","article-title":"RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Rad","volume":"44","author":"Chai","year":"2008","journal-title":"Biol. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0200","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2008.08.074","article-title":"RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells","volume":"375","author":"Shan","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0205","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","article-title":"Central hypothyroidism associated with retinoid X receptor-selective ligands","volume":"340","author":"Sherman","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0210","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI1581","article-title":"Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids","volume":"102","author":"Vu-Dac","year":"1998","journal-title":"J. Clin. Inv."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0220","doi-asserted-by":"crossref","first-page":"12503","DOI":"10.1074\/jbc.C200004200","article-title":"The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor \u03b3 ligands","volume":"277","author":"Forman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0225","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/jm020340q","article-title":"Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid x receptor modulators are active in models of type 2 diabetes","volume":"46","author":"Michellys","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0230","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm020401k","article-title":"Design, synthesis and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids","volume":"46","author":"Michellys","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0235","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.bmcl.2003.12.089","article-title":"Design, synthesis and structure-activity relationship of novel RXR-selective modulators","volume":"14","author":"Michellys","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0240","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/01.ATV.0000248101.93488.84","article-title":"The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia","volume":"26","author":"Lalloyer","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0245","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-\u03b1","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0250","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/emboj\/19.11.2592","article-title":"Crystal structure of the human RXR\u03b1 ligand-binding domain bound to its natural ligand: 9-cis-retinoic acid","volume":"19","author":"Egea","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nsb0398-199","article-title":"Conformational adaptation of agonists to the human nuclear receptor RAR\u03b3","volume":"5","author":"Klaholz","year":"1998","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0260","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/mend.16.5.0823","article-title":"Molecular recognition of agonist ligands by RXRs","volume":"16","author":"Egea","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1097-2765(00)80424-4","article-title":"Crystal structure of a heterodimeric complex of raR and RXR ligand-binding domains","volume":"5","author":"Bourguet","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0270","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1093\/emboj\/cdg456","article-title":"Crystal structure of the heterodimeric complex of LXR[alpha] and RXR[beta] ligand-binding domains in a fully agonistic conformation","volume":"22","author":"Svensson","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0275","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1074\/jbc.M110869200","article-title":"The structural basis for the specificity of retinoid-X-receptor-selective agonists: new insights into the role of helix H12","volume":"277","author":"Love","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0280","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1021\/jm900096q","article-title":"Modulating retinoid X receptor with a series of (E)-3-[4-Hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers","volume":"52","author":"P\u00e9rez-Sant\u00edn","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0285","doi-asserted-by":"crossref","first-page":"17323","DOI":"10.1073\/pnas.0705356104","article-title":"Modulators of the structural dynamics of RXR to reveal receptor function","volume":"104","author":"Nahoum","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0290","doi-asserted-by":"crossref","first-page":"e15119","DOI":"10.1371\/journal.pone.0015119","article-title":"The \"Phantom Effect\" of the rexinoid LG100754: structural and functional insights","volume":"5","author":"Sato","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0295","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/mrc.2515","article-title":"The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain","volume":"47","author":"Lu","year":"2009","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/415187a","article-title":"Co-regulator recruitment and the mechanism of retinoic acid receptor synergy","volume":"415","author":"Germain","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0305","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1097-2765(00)80448-7","article-title":"Asymmetry in the PPAR\u03b3\/RXR\u03b1 crystal structure reveals the molecular basis of heterodimerization among nuclear receptors","volume":"5","author":"Gampe","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0310","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1074\/jbc.M409302200","article-title":"Characterization of the interaction between RAR\/RXR heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies","volume":"280","author":"Pogenberg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.embor.7400119","article-title":"Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level","volume":"5","author":"Brelivet","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0320","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0092-8674(04)00119-9","article-title":"Structural determinants of allosteric ligand activation in RXR heterodimers","volume":"116","author":"Shulman","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0325","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nsmb.1855","article-title":"A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor","volume":"17","author":"le Maire","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0330","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR\u03b3-RXR\u03b1 nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0335","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cmdc.200700313","article-title":"The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXR\u03b1\/\u03b2-dual agonist)","volume":"3","author":"Takamatsu","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0340","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/cmdc.200700265","article-title":"Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXR\u03b1-preferential agonist possessing a sulfonamide moiety","volume":"3","author":"Takamatsu","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0345","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bmcl.2008.11.086","article-title":"Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity","volume":"19","author":"Morishita","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0350","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1753-4887.2006.tb00186.x","article-title":"Is 9-cis-retinoic acid the endogenous ligand for the retinoic acid-X receptor?","volume":"64","author":"Wolf","year":"2006","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0355","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1101\/gad.368706","article-title":"Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes","volume":"20","author":"Call\u00e9ja","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0360","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/mol.109.060038","article-title":"Activation of retinoic acid receptors by dihydroretinoids","volume":"76","author":"Moise","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0365","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nm1587","article-title":"Retinaldehyde represses adipogenesis and diet-induced obesity","volume":"13","author":"Ziouzenkova","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/me.2006-0225","article-title":"Asymmetric cleavage of {beta}-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses","volume":"21","author":"Ziouzenkova","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0375","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1126\/science.290.5499.2140","article-title":"Docosahexaenoic Acid, a Ligand for the Retinoid X Receptor in Mouse Brain","volume":"290","author":"de Urquiza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0380","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1073\/pnas.92.13.6157","article-title":"Activation of mammalian retinoid X receptors by the insect growth regulator methoprene","volume":"92","author":"Harmon","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0385","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1091\/mbc.7.8.1153","article-title":"Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR","volume":"7","author":"Kitareewan","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0390","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-1033.1996.00328.x","article-title":"Phytanic acis is a retinoid X receptor ligand","volume":"236","author":"LeMotte","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0395","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0022-2275(20)31973-8","article-title":"Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor \u03b3","volume":"41","author":"Zomer","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0400","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/np100120c","article-title":"Identification of a naturally occurring rexinoid, honokiol. that activates the retinoid X receptor","volume":"73","author":"Kotani","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0405","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nrd2398","article-title":"Design of selective nuclear receptor modulators: RAR and RXR as a case study","volume":"6","author":"de Lera","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0410","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/jm00044a014","article-title":"Synthesis and structure\u2013activity relationships of novel retinoid X receptor-selective retinoids","volume":"37","author":"Boehm","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0415","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0960-894X(01)80511-4","article-title":"Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs","volume":"4","author":"Beard","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0420","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/jm00015a004","article-title":"Synthesis and structure\u2013activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids","volume":"38","author":"Beard","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0425","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0705113","article-title":"RXR activators molecular signalling: involvement of a PPAR\u03b1-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart","volume":"138","author":"Ouamrane","year":"2003","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0430","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/jm980621r","article-title":"Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells","volume":"42","author":"Canan-Koch","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0435","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1021\/jo0103064","article-title":"Synthesis of novel retinoid X receptor-selective retinoids","volume":"66","author":"Faul","year":"2001","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0440","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/endo.142.3.8037","article-title":"Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor \u03b3 activation has coordinate effects on gene expression in multiple insulin-sensitive tissues","volume":"142","author":"Way","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0445","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1074\/jbc.275.17.12612","article-title":"Induction of the fatty acid transport protein 1 and acyl-coa synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target","volume":"275","author":"Martin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0450","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.ATV.18.2.272","article-title":"RXR agonists activate ppar\u03b1-inducible genes, lower triglycerides, and raise HDL levels in vivo","volume":"18","author":"Mukherjee","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0455","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1568011043352975","article-title":"Synthetic retinoids and their nuclear receptors","volume":"4","author":"Dawson","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0460","doi-asserted-by":"crossref","first-page":"30765","DOI":"10.1074\/jbc.270.51.30765","article-title":"Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor","volume":"270","author":"Apfel","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0465","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1152\/ajpendo.00313.2001","article-title":"RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor","volume":"283","author":"Macchia","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0470","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1248\/bpb.28.1192","article-title":"A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice","volume":"28","author":"Deng","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0475","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/jm960311d","article-title":"Identification of the first retinoid x receptor homodimer antagonist","volume":"39","author":"Canan Koch","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0480","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gad.11.3.299","article-title":"The phantom ligand effect: allosteric control of transcription by the retinoid X receptor","volume":"11","author":"Schulman","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0485","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1021\/jm9704309","article-title":"Regulation of retinoidal actions by diazepinylbenzoic acids. retinoid synergists activate the RXR\u2013RAR heterodimers","volume":"40","author":"Umemiya","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0490","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1021\/jm0255320","article-title":"Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR\u2013RAR heterodimers","volume":"45","author":"Takahashi","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0495","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.metabol.2004.11.013","article-title":"A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions","volume":"54","author":"Yotsumoto","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2011.04.003_bb0500","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.bmcl.2007.06.080","article-title":"Synthesis and structure\u2013activity relationship of novel RXR antagonists: orally active anti-diabetic and anti-obesity agents","volume":"17","author":"Sakaki","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0505","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1016\/j.bmcl.2007.06.079","article-title":"Synthesis and structure\u2013activity relationship of RXR antagonists based on the diazepinylbenzoic acid structure","volume":"17","author":"Sakaki","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0510","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1248\/bpb.21.544","article-title":"Potent retinoid synergists with a diphenylamine skeleton","volume":"21","author":"Ohta","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0515","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bcp.2008.08.005","article-title":"The RXR agonists PA024 and HX630 have different abilities to activate LXR\/RXR and to induce ABCA1 expression in macrophage cell lines","volume":"76","author":"Nishimaki-Mogami","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0520","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/ml100184k","article-title":"Modification at the lipophilic domain of RXR agonists differentially influences activation of RXR heterodimers","volume":"1","author":"Ohsawa","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0525","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.bmcl.2007.01.047","article-title":"RXR\u2013LXR heterodimer modulators for the potential treatment of dyslipidemia","volume":"17","author":"Lagu","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0530","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmcl.2007.01.049","article-title":"Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia","volume":"17","author":"Lagu","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0535","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.1997.15.2.790","article-title":"Initial clinical trial of a selective retinoid X receptor ligand, LGD1069","volume":"15","author":"Miller","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0540","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198510173131604","article-title":"Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne","volume":"313","author":"Bershad","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.04.003_bb0545","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/94156","article-title":"Therapeutic potential of rexinoid X receptor modulators for the treatment of the metabolic syndrome","author":"Pinaire","year":"2007","journal-title":"PPAR Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:57:26Z","timestamp":1637531846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1388198111000461"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.04.003","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}